| P2093 | author name string | Dirk Albrecht | |
| | Peter Angele | |
| | Johannes Zellner | |
| | Jason Koh | |
| | Juergen Fritz | |
| P2860 | cites work | Repair of large chondral defects of the knee with autologous chondrocyte implantation in patients 45 years or older | Q81824720 |
| | Matrix-induced autologous chondrocyte implantation versus microfracture in the treatment of cartilage defects of the knee: a 2-year randomised study | Q82455832 |
| | Autologous chondrocyte implantation: a long-term follow-up | Q83022840 |
| | Remodeling of articular cartilage and subchondral bone after bone grafting and matrix-associated autologous chondrocyte implantation for osteochondritis dissecans of the knee | Q83070372 |
| | Two- to 9-year outcome after autologous chondrocyte transplantation of the knee | Q28144816 |
| | Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation | Q28247673 |
| | Results 2 Years After Matrix-Associated Autologous Chondrocyte Transplantation Using the Novocart 3D Scaffold: An Analysis of Clinical and Radiological Data. | Q30818691 |
| | Autologous chondrocyte implantation compared with microfracture in the knee. A randomized trial. | Q34302678 |
| | Intravenous administration of anti-vascular endothelial growth factor humanized monoclonal antibody bevacizumab improves articular cartilage repair | Q34346264 |
| | A prospective, randomised study comparing two techniques of autologous chondrocyte implantation for osteochondral defects in the knee: Periosteum covered versus type I/III collagen covered | Q34518529 |
| | Reoperation after autologous chondrocyte implantation. Indications and findings | Q35717000 |
| | Comparison of marker gene expression in chondrocytes from patients receiving autologous chondrocyte transplantation versus osteoarthritis patients | Q36392260 |
| | Is the transplant quality at the time of surgery adequate for matrix-guided autologous cartilage transplantation? A pilot study | Q37072306 |
| | The John Insall Award: A minimum 10-year outcome study of autologous chondrocyte implantation | Q37469062 |
| | Failures, re-operations, and complications after autologous chondrocyte implantation--a systematic review. | Q37844789 |
| | Mechanisms and targets of angiogenesis and nerve growth in osteoarthritis. | Q38013959 |
| | Treatment and Prevention of (Early) Osteoarthritis Using Articular Cartilage Repair-Fact or Fiction? A Systematic Review | Q38526254 |
| | Graft hypertrophy of matrix-based autologous chondrocyte implantation: a two-year follow-up study of NOVOCART 3D implantation in the knee | Q43539441 |
| | Pronounced biomaterial dependency in cartilage regeneration using nonexpanded compared with expanded chondrocytes | Q43586499 |
| | Influence of cell differentiation and IL-1β expression on clinical outcomes after matrix-associated chondrocyte transplantation | Q44934910 |
| | A prospective study of autologous chondrocyte implantation in patients with failed prior treatment for articular cartilage defect of the knee: results of the Study of the Treatment of Articular Repair (STAR) clinical trial | Q44942229 |
| | Articular cartilage defects in the knee--basics, therapies and results | Q47683203 |
| | Autologous chondrocyte implantation in children and adolescents | Q47818362 |
| | Analysis of the autologous chondrocyte quality of matrix-based autologous chondrocyte implantation in the knee joint | Q49021813 |
| | Revision surgery after third generation autologous chondrocyte implantation in the knee | Q49077175 |
| | Tibial plateau lesions. Surface reconstruction with a biomimetic osteochondral scaffold: Results at 2 years of follow-up. | Q51072256 |
| | Autologous chondrocyte implantation: natural history of postimplantation periosteal hypertrophy and effects of repair-site debridement on outcome. | Q51095481 |
| | Magnetic resonance observation of cartilage repair tissue (MOCART) for the evaluation of autologous chondrocyte transplantation: determination of interobserver variability and correlation to clinical outcome after 2 years. | Q51344391 |
| | Autologous chondrocyte implantation for treatment of focal cartilage defects in patients age 40 years and older: A matched-pair analysis with 2-year follow-up. | Q51662621 |
| | Influence of cell quality on clinical outcome after autologous chondrocyte implantation. | Q53139658 |
| | The incidence and clinical relevance of graft hypertrophy after matrix-based autologous chondrocyte implantation. | Q53143120 |
| | Is microfracture of chondral defects in the knee associated with different results in patients aged 40 years or younger? | Q53247254 |
| | Injury patterns of medial patellofemoral ligament and correlation analysis with articular cartilage lesions of the lateral femoral condyle after acute lateral patellar dislocation in children and adolescents: An MRI evaluation. | Q53601052 |
| | Autologous chondrocyte implantation in the patella: a multicenter experience | Q56770412 |
| | A correlation between the timing of biopsy after autologous chondrocyte implantation and the histological appearance | Q57572795 |
| | The influence of scaffold architecture on chondrocyte distribution and behavior in matrix-associated chondrocyte transplantation grafts | Q58835658 |
| | Minimum ten-year results of a prospective randomised study of autologous chondrocyte implantation versus mosaicplasty for symptomatic articular cartilage lesions of the knee | Q60194088 |
| | Treatment of osteochondritis dissecans of the knee with autologous chondrocyte transplantation: results at two to ten years | Q73331063 |
| | Autologous chondrocyte implantation for focal chondral defects of the knee | Q74625586 |
| | [Significance and technique of autologous chondrocyte transplantation] | Q81069113 |
| P304 | page(s) | S2-9 | |
| P577 | publication date | 2015-10-01 | |
| P1433 | published in | Injury | Q15752765 |
| P1476 | title | Defect type, localization and marker gene expression determines early adverse events of matrix-associated autologous chondrocyte implantation. | |
| P478 | volume | 46 Suppl 4 | |